ACTR1A Protein (Myc-DYKDDDDK Tag)

N° du produit ABIN2713914

Cette protéine Recombinant ACTR1A est produite dans HEK-293 Cells.

Aperçu rapide pour ACTR1A Protein (Myc-DYKDDDDK Tag) (ABIN2713914)

Antigène: ACTR1A (Alpha Centractin (ACTR1A))

Type de proteíne: Recombinant

Origine: Humain

Source: HEK-293 Cells

Application: Antibody Production (AbP), Standard (STD)

Pureté: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Détail du produit

Purification/Conjugué: Cette ACTR1A protéine est marqué à la Myc-DYKDDDDK Tag.

Attributs du produit:

• Recombinant human Centractin alpha protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Information d'application

Indications d'application: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Commentaires:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Stockage

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Stock: -80 °C

Stockage commentaire: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Détail du antigène

Antigène: ACTR1A (Alpha Centractin (ACTR1A))

Autre désignation: Centractin alpha

Sujet: This gene encodes a 42.6 kD subunit of dynactin, a macromolecular complex consisting of 10-11 subunits ranging in size from 22 to 150 kD. Dynactin binds to both microtubules and cytoplasmic dynein. It is involved in a diverse array of cellular functions, including ER-to-Golgi transport, the centripetal movement of lysosomes and endosomes, spindle formation, chromosome movement, nuclear positioning, and axonogenesis. This subunit is present in 8-13 copies per dynactin molecule, and is the most abundant molecule in the dynactin complex. It is an actin-related protein, and is approximately 60 % identical at the amino acid level to conventional actin.

Poids moléculaire: 42.4 kDa

NCBI Accession: NP_005727

Pathways: M Phase